Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$12.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$10.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.35M |
| 4 |
Workday
WDAY
|
+$7.63M |
| 5 |
Coca-Cola
KO
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$15.4M |
| 2 |
Amgen
AMGN
|
+$11.2M |
| 3 |
Salesforce
CRM
|
+$9.62M |
| 4 |
Danaher
DHR
|
+$9.18M |
| 5 |
Union Pacific
UNP
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.33% |
| 2 | Consumer Discretionary | 16.35% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 8.63% |
Similar funds
Bayesian Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Bayesian Capital Management held 1,036 positions worth $604M, down 26% from $817M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management withdrew a net $186M in Q1 2025, closing 470 positions and reducing 105 holdings. Its most notable exit was Amgen, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Advanced Micro Devices worth $9.96M.
- Bayesian Capital Management's largest Q1 2025 buy was Advanced Micro Devices: 96,900 shares worth $9.96M.
- Bayesian Capital Management added most to Cisco in Q1 2025, an estimated $12.4M increase.
- Bayesian Capital Management's biggest Q1 2025 reduction was Nike, cutting an estimated $15.4M.
- Bayesian Capital Management fully exited Amgen in Q1 2025, selling an estimated $11.2M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $604M portfolio in Q1 2025.
- Bayesian Capital Management opened 389 new positions and closed 470 in Q1 2025.
- Bayesian Capital Management's portfolio value fell 26% quarter-over-quarter to $604M.
Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.